News for Aikido Pharma Inc (BP2M.BE)

Today's Daily Dose brings you news about Nektar's collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharma's strategic financing; and vTv Therapeutics' initiation of a phase 1 multiple ascending dose study of HPP737.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

TMSR Holding Co Ltd operates in two business divisions that are Shengrong, which engages in the production and sales of solid waste recycling and comprehensive ...

Today's Daily Dose brings you news about Applied Genetic's Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWork's progress with ZW49 study.

Today's Daily Dose brings you news about the progress of Vaxart's oral tablet COVID-19 vaccine candidate; Vir Biotech's phase I trial of VIR-3434 in chronic hepatitis B virus; Sorrento's COVID-19 program; Agios Pharma's phase III trial of Mitapivat and Johnson & Johnson's rosy outlook for 2021.

NEW YORK, Jan.?22, 2021 /PRNewswire/ -- AIkido Pharma Inc. today announced that on January 22, 2021, the Company received a letter from the Listing Qualifications Department of The NASDAQ... | January 22, 2021

AIkido Pharma Inc. (Nasdaq: AIKI) (

What's moving these stocks in pre-market hours today?.

Marijuana Stocks Aren’t The Only Thing Exciting Vice Investors Right Now Those who’ve traded penny stocks really get to have an early look at emerging indu...

SILO stock is making a run for the top after announcing that it has entered into a licensing agreement with AIKI.

(RTTNews) - What's moving these stocks in pre-market hours today? In the Green 1. Ocugen Inc. (OCGN) is up nearly 79% at $3.29 in pre-market hou...